CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 128 enrolled
Drug / intervention
Ketorolac +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03727048
NCT03727048Phase 4Completed
CompareCT.gov

Effect of Toradol on Post-operative Foot and Ankle Healing

Rothman Institute Orthopaedics·interventional·Posted Nov 1, 2018·Updated Nov 1, 2018

In Brief

A Phase 4 clinical trial evaluating Ketorolac and No ketorolac for Ankle Fractures and Trauma Injury. Completed, enrolled 128 participants.

Detailed Summary

The use of Toradol for pain control in surgical orthopedic cases is currently a topic of interest within the field. The proposed study is a prospective randomized study evaluating postoperative pain, opioid requirement, complication/reoperation rates and nonunion rates in patients undergoing surgical treatment for isolated lateral malleolar fibula fractures. Patients will be randomized to either the Treatment Group (Toradol) or the Control Group (Non-Toradol). Both Toradol and non-Toradol drug regimens are currently prescribed by the Foot and Ankle Team at the Rothman Institute and this study will serve as a valuable comparison.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnkle Fractures, Trauma Injury
Countries--
Collaborators--

Timeline

Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedNov 1, 2018
Enrollment StartAug 1, 2016
Primary CompletionMar 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 7.7 years ago

Interventions

Ketorolacdrug

the investigators aimed to evaluate the effect of postoperative ketorolac after ankle fracture surgery on postoperative opioid consumption, pain control, an patient satisfaction.

No ketorolacother

standard of care post operative pain management protocol